Both in Surgical Instruments
Treace Medical Concepts vs Orchestra BioMed Holdings
Over the past year TMCI returned −30.7% and OBIO returned +51.5%; their daily moves had a correlation of 0.15.
TMCI −30.7% OBIO +51.5%Growth of $1, one year, split-adjusted
| Metric | TMCI | OBIO |
|---|---|---|
| Price | $4.43 | $5.91 |
| Market cap | $288.1M | $355.2M |
| Today | −12.45% | −2.96% |
| 1 month | +2.3% | −6.9% |
| 6 months | +138.2% | +48.9% |
| Year to date | +80.8% | +42.4% |
| 1 year | −32.4% | +63.7% |
| Revenue growth (YoY) | −4.2% | −89.5% |
| Gross margin | 78.5% | 71.6% |
| Net margin | −35.0% | −27362.5% |
| P/E (TTM) | — | — |
| Price / sales | 1.4× | 11.1× |
| Net cash | -$10.4M | $75.1M |
| Dividend yield | — | — |
| Volatility (60d) | 62.3% | 63.2% |
| Short % of float | 4.0% | 8.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).